ðŸð± ç¬ç«ãã¥ãŒã¹ â 2026.09.12
ç¬4 ïŒ ç«2 ïŒ èš6ä»¶
ðŸ ç¬ãã¥ãŒã¹ â 2026.09.12
æ¬æ¥ 4ä»¶
1. â ïž ãªã³ãŒã«ã»å®å šæ å ±
ç¬çšãµããªãFiãã®2補åãããµã«ã¢ãã©ã®æãââãCalmingããšã8-in-1 Formulaãã®å1ããããååãAmazonãChewyã§ã販売ãåå ã¯è£œé å§èšå ã«çŽå ¥ãããåææãå·¥å Žã¯çç£ãäžæåæ¢
ð 2026.09.08
ç±³ãã¥ãŒãšãŒã¯ã®äŒæ¥FiïŒè²©å£²å ã¯Vet Plus, Inc.ïŒããç¬çšãµããªã¡ã³ã2補åãèªäž»ååãããšçºè¡šããç±³é£åå»è¬åå±ïŒFDAïŒã9æ8æ¥ã«å ¬è¡šããã察象ã¯ãFi Calming supplement for Dogs 180gãïŒãããçªå·26118ãUPC 8 50064 80011 1ïŒãšãFi 8-in-1 Formula supplement for Dogs 180gãïŒãããçªå·26159ãUPC 8 50055 11168 4ïŒã®2ã€ã§ããããããµã«ã¢ãã©ã«æ±æãããŠããå¯èœæ§ããããåå ã¯ãFiã®è£œé å§èšå ã«çŽå ¥ãããåææã«ãããšããã補é å ã¯èª¿æ»ã®ããçç£ãäžæåæ¢ããŠããã補åã¯å瀟ããã®çŽè²©ã«å ããAmazonãšChewy.comãéããŠè²©å£²ãããŠãããäŒç€Ÿçºè¡šã¯9æ3æ¥ä»ã§ãFiã¯åœ±é¿ãåãã顧客ã«ã念ã®ãããçŽæ¥éç¥ããŠãããšãããçŸæç¹ã§ç¬ã人ã®å¥åº·è¢«å®³ã®å ±åã¯çºè¡šæã«èšèŒãããŠããªãããµã«ã¢ãã©ã«ææããç¬ã¯å æ°æ¶å€±ãäžç¢ãè¡äŸ¿ãçºç±ãååã瀺ãããšãããã飿¬²äœäžãšè ¹çã ãã®å Žåããããããã«ãçç¶ããªããŠãä¿èç¶æ ãšãªããã»ãã®åç©ãäººã«ææãåºããå¯èœæ§ããããšFDAã¯æ³šæãä¿ããŠããã
Fiã¯æ¥æ¬ã§ã¯GPSä»ãã¹ããŒãéŠèŒªã®ãã©ã³ããšããŠç¥ãããŠãããã察象ãšãªã£ããµããªã¡ã³ãã¯ç±³åœå åãã®è²©å£²ãäžå¿ã§ãæ¥æ¬åœå ã§ã®æ£èŠæµéã¯ç¢ºèªãããŠããªãããã ããæµ·å€é販ã䞊è¡èŒžå ¥ã§ç±³åœè£œã®ç¬çšãµããªãè³Œå ¥ããŠããå®¶åºã¯ããããçªå·ãšUPCã念ã®ããç §åããŠã»ããã該åœè£œåãæã£ãŠããå Žåã¯äœ¿çšãäžæ¢ãã容åšããã£ããå¯éããŠãã¿ãšããŠå»æ£ããããæ¡å ãããŠããããµããªã¡ã³ãã¯ããŒããšéã£ãŠãå°éã ããå®å šããšæãããã¡ã ãããµã«ã¢ãã©ã¯éã«é¢ä¿ãªãææããããããçµŠäžæã«äººã®æã«ãä»çãããç¬ã«äžããããšã¯æãæŽãã調çå°ãé£åšãšåããŠä¿ç®¡ããããšãåºæ¬ã ãæç¬ã«äžç¢ãååãå æ°æ¶å€±ãèŠãããå Žåã¯ãäžããŠãããµããªã®ååãšãããçªå·ãã¡ã¢ããŠç£å»åž«ã«çžè«ããŠã»ããã
ð·ïž ãªã³ãŒã«ã»å®å šæ å ±
2. ð¥ å»çã»çŸç ã»äºé²
ç¬ç«ãæã€èºçæ¡¿èã®87%ã¯ã人ãšåã系統ãã ã£ãââè±ããŒã³ãã¹å€§ã25ã«åœ712æ ªã®ã²ãã ãäººç±æ¥3äž8000æ ªãšæ¯èŒãESBLéºäŒåã¯43%ãã«ã«ãããããŒãŒéºäŒåã¯14%ã®æ ªããæ€åº
ð 2026.08.28
è±ããŒã³ãã¹å€§åŠãšãŠãããŒã·ãã£ã»ãã¹ãã¿ã«ãºã»ããŒã»ããã®ç ç©¶ããŒã ããç¬ãšç«ããåé¢ãããèºçæ¡¿èïŒKlebsiella pneumoniaeïŒ712æ ªã®ã²ãã ããŒã¿ãäžçèŠæš¡ã§éããäººç±æ¥ã®3äž8106æ ªãšæ¯èŒããçµæãåŠè¡èªTransboundary and Emerging Diseasesã«çºè¡šãããèºçæ¡¿èã¯å°¿è·¯ææãè¡æµææãèºçã®åå ãšãªã现èã§ãè¬å€èæ§ãç²åŸãããšæ²»çãé£ãããªãããšãããWHOãæåªå ã®èæ§èã«æããŠãããè§£æã®çµæã䌎䟶åç©ç±æ¥ã®æ ªã¯263çš®é¡ã®é ååïŒSTïŒã«åããããããã®ãã¡äººã®å»ççŸå Žã§åé¡ãšãªã£ãŠããããã€ãªã¹ã¯ç³»çµ±ãST307ãST11ãST15ãST147ãç¹°ãè¿ãæ€åºããããåœæ å ±ã®ãã706æ ªã®ãã¡ã第3äžä»£ã»ãã¡ãã¹ããªã³ãåè§£ããESBLéºäŒåãæã€æ ªã¯303æ ªïŒ42.9%ïŒãæåŸã®ç Šãšãããã«ã«ãããã ç³»æèè¬ãåè§£ããã«ã«ãããããŒãŒéºäŒåãæã€æ ªã¯98æ ªïŒ13.9%ïŒã«äžã£ããå€å€èæ§ã®å²åã¯ç«ç±æ¥ã§80.0%ãç¬ç±æ¥ã§56.3%ãšãç«ã®ã»ããé«ãã£ãããããŠäŒŽäŸ¶åç©ç±æ¥ã®STã®ãã¡71.1%ãæ ªæ°ããŒã¹ã§ã¯87.2%ãã人ãããæ€åºãããŠããSTã«å±ããŠãããST147系統ã詳ãã調ã¹ããšãç«ã»ç¬ã»äººã®ã²ãã ã1ã€ã®è¿çžã¯ã©ã¹ã¿ãŒã«æ··åšããŠããã宿䞻ããŸããã§æ¯èŒçæè¿ã«å ±éç¥å ããåºãã£ãããšã瀺åããŠãããå€å€èæ§æ ªã¯ææçã®æ€äœã ãã§ãªããå¥åº·ãªåç©ã®ç³äŸ¿ãªã©ãããèŠã€ãã£ãŠããããç¡çç¶ã®ä¿èããèæ§èã®æž©åºã«ãªããããšç ç©¶ããŒã ã¯ææããŠããã
ç ç©¶ãçããããŒã³ãã¹å€§åŠã®ã¹ãã£ãŒãã³ã»ãã©ãŒãã å士ã¯ããã®çµæã¯ããããã人ãç æ°ã«ããŠãããããšã瀺ããã®ã§ã¯ãªãã飌ãäž»ãå¿é ããå¿ èŠã¯ãªããšããããã§ãèæ§è察çã®æ çµã¿ã«ããããçµã¿èŸŒãéèŠæ§ã匷調ããŠãããå°åå¥ã«èŠããšESBLã»ã«ã«ãããããŒãŒéºäŒåã®ä¿æçã¯ã¢ãžã¢ã60.5%ãšæãé«ããéåœã®æ ªã¯89.7%ãäžåœã¯52.4%ã ã£ããæ¥æ¬ã®æ ªã¯ä»åã®ããŒã¿ã»ããã«ã¯å«ãŸããŠããªãããåç©ç é¢ã§ã®æèè¬äœ¿çšã¯æ¥æ¬ã§ã課é¡ã§ãããèŸ²ææ°Žç£çãè¬å€èæ§ïŒAMRïŒå¯Ÿçã¢ã¯ã·ã§ã³ãã©ã³ã§äŒŽäŸ¶åç©ã®æèè¬é©æ£äœ¿çšãæ²ããŠããã飌ãäž»ã«ã§ããããšã¯ãç£å»åž«ãåŠæ¹ããæèè¬ãèªå·±å€æã§äžæã»åå©çšããªãããšãææ³ç©ã®åŠçåŸãç¬ã«è§Šããããšã«æãæŽãããšããããŠã念ã®ãããã®æèè¬ãæ±ããªãããšã ãèè±çãç®èçãç¹°ãè¿ãç¬ã§ã¯ãå¹é€æ€æ»ãšæåæ§è©Šéšã«åºã¥ããŠè¬ãéžã¶ããšãèæ§èãå¢ãããªãè¿éã«ãªããå ç«ãèœã¡ãŠããå®¶æãé«éœ¢è ãããå®¶åºã§ã¯ãããããšã®æ¥ãæ¹ã«ã€ããŠç£å»åž«ã«çžè«ããŠã»ããã
ð https://pmc.ncbi.nlm.nih.gov/articles/PMC13522988/
ð·ïž å»çã»çŸç ã»äºé²
3. 𧬠ç ç©¶ã»ç§åŠ
ãç¬ã¢ã¬ã«ã®ãŒã®äž»ç¯ãCan f 1ãäœããªãããŒã°ã«ãèªçââç±³äŒæ¥ãCRISPRã§éºäŒåãç·šéãåŸæ¶²ã»æ¯ã»ãã±ããæ€åºããããããŒãã«ããŽãŒã«ãã³ãã¥ãŒãã«ã§ã¯æ€åºã人ã®ç®èãã¹ãã§ãåå¿ãªã
ð 2026.08.19
ç±³ãã¥ãŒãšãŒã¯ã®ãã€ãªãã¯ãããžãŒäŒæ¥Kindred Companion Sciencesã®ç ç©¶ããŒã ããç¬ã¢ã¬ã«ã®ãŒã®äž»èŠã¢ã¬ã«ã²ã³ã§ããã¿ã³ãã¯è³ªCan f 1ãç£çããªãããŒã°ã«2é ããã²ãã ç·šéæè¡CRISPR-Cas9ã§èªçããããšãç§åŠèªThe CRISPR Journalã«8æ5æ¥ä»ã§çºè¡šãããç¬ã¢ã¬ã«ã®ãŒã¯äººå£ã®ããã15%ã«ã¿ããã錻çã忝ãšãé¢ãããããã®åå ã¯æ¯ãã®ãã®ã§ã¯ãªããç¬ãäœãè€æ°ã®ã¢ã¬ã«ã²ã³ã¿ã³ãã¯è³ªã§ããããªãã§ãCan f 1ã¯æãéèŠãªåå ç©è³ªãšããããç ç©¶ããŒã ã¯éããŒã°ã«ç±æ¥ã®ç·ç¶èœçްèã§Can f 1éºäŒåãæšçã«ç·šéãã1å¡©åºã®æ¿å ¥ã§èªã¿æ ããããŠæ£åžžãªã¿ã³ãã¯è³ªãäœããªããªã£ã现èãéžæãäœçŽ°èæ žç§»æ€ã«ããã¯ããŒã³æè¡ã§25åã®èãäœè£œããŠä»£çæ¯ã«ç§»æ€ãããã®ãã¡2åãåºç£ã«è³ã£ãŠã2024幎9æã«AlfieãšBaileyãšãã2é ã®éãçãŸãããå šã²ãã è§£æã§ã¯æšç以å€ã®éºäŒåã誀ã£ãŠç·šéããã圢跡ãæè²äœã¬ãã«ã®å€§ããªç°åžžã¯èŠã€ãããªãã£ãã2é ã®åŸæ¶²ãæ¯ããã±ããã¯Can f 1ãæ€åºãããªãã£ãäžæ¹ãéåžžã®ããŒã°ã«ã ãã§ãªããäœã¢ã¬ã«ã®ãŒæ§ããšãããã¹ã¿ã³ããŒãããŒãã«ããŽãŒã«ãã³ãã¥ãŒãã«ã®åŸæ¶²ãããCan f 1ãã¯ã£ããæ€åºããããCan f 1ã«ç¹ç°çãªIgEæäœãæã€æäººç·æ§1人ã§ç®èããªãã¯ãã¹ããè¡ã£ããšãããéåžžã®ããŒã°ã«ç±æ¥ã®è©Šæã§ã¯çŽ6mmã®èšç¹ãã§ããããŒãã«ããŽãŒã«ãã³ãã¥ãŒãã«ã§ã匷ãåå¿ãåºãããç·šéããŒã°ã«ç±æ¥ã®è©Šæã§ã¯æ€åºå¯èœãªèšç¹ã¯çããªãã£ãã
ãã®ç ç©¶ã¯ãç¬ã¢ã¬ã«ã®ãŒå¯Ÿçãã人éåŽã®å ç«ãå€ãããã®ã§ã¯ãªããç¬åŽã®ã¢ã¬ã«ã²ã³ã®çºçæºãåãé€ãããšããçºæ³ã§ç€ºããæŠå¿µå®èšŒãšãããããã ãéçãå€ãã人ã§ã®è©Šéšã¯ããã1人ã§ãããç¬ã¢ã¬ã«ã®ãŒã«ã¯Can f 1以å€ã®Can f 2ã6ãªã©ã«åå¿ãã人ããããCan f 1ãç¬èªèº«ã®äœã§ã©ããªåœ¹å²ãæ ã£ãŠãããã¯ãŸã åãã£ãŠãããã2é ã¯ãããŸã§ã®ç£å»åŠçæ€æ»ãæé·ãXç·ç»åã§ç°åžžã瀺ããŠããªããã®ã®ãé·æçãªå¥åº·åœ±é¿ã¯ä»åŸã®ç¢ºèªãå¿ èŠã ããŸããå®¶åºç¬ã«ã²ãã ç·šéãšã¯ããŒã³æè¡ãçšããããšã®å«ççãªè°è«ã¯é¿ãããããæ¥æ¬ã§ã¯ããããç¬ãæµéããèŠèŸŒã¿ã¯åœé¢ãªããæ¥æ¬ã®é£Œãäž»ã«ãšã£ãŠçŸå®çãªç€ºåã¯ããããŒãã«ç³»ã ããã¢ã¬ã«ã®ãŒãåºãªãããšããæã蟌ã¿ã¯æ ¹æ ã匱ããšããç¹ã ãå®¶æã«ç¬ã¢ã¬ã«ã®ãŒã®äººãããå Žåã¯ãç¬çš®åã§å€æããã®ã§ã¯ãªããè¿ããåã«å®éã®ç¬ãšæ¥è§ŠããŠåå¿ã確ãããããšãããŸããªãã©ãã·ã³ã°ãç©ºæ°æž æµæ©ãå¯å®€ã«å ¥ããªããªã©ã®ç°å¢å¯Ÿçãçµã¿åãããããšãåºæ¬ã«ãªããçç¶ã匷ãå Žåã¯ã¢ã¬ã«ã®ãŒå°éå»ã«çžè«ããŠã»ããã
ð https://nazology.kusuguru.co.jp/archives/198799
4. ð ç¬åŠ
ãã¯ã¯ã®ãå°ããªäœã«å€§ããªæ 床ãã®è£ã«ã³ãšãŒãã®è¡ââææ°ã²ãã è§£æã§éçã³ãšãŒãç±æ¥ã®éºäŒåã倿ãå äœæ°æä»£ã®åšæ¥ç¬ã®è¡ã4%æ®åãããªãã³ã°ã®ãªãªã«ããããããã¯ã¯ã®äžã®ã³ãšãŒããããè±ãããã£ã³ã¬ã ã»ãã¬ã³ã倧ã®åç©ç§åŠè ã解説
ð 2026.09.11
äžçæå°çŽã®ç¬çš®ãã¯ã¯ããéçã®ã³ãšãŒãã®éºäŒåãåãç¶ãã§ããããšãæè¿çºè¡šãããã²ãã ç ç©¶ã§ç€ºããããšãè±ãããã£ã³ã¬ã ã»ãã¬ã³ã倧åŠã®åç©ç§åŠè ãžã£ã¯ãªãŒã³ã»ãã€ãæ°ã9æ11æ¥ä»ã§The Conversationã«è§£èª¬èšäºãå¯çš¿ãããããšã«ãªã£ãã®ã¯ç±³ã¹ã¿ã³ãã©ãŒã倧åŠãªã©ã®ç ç©¶è ã7æ25æ¥ä»ã§åŠè¡èªNature Communicationsã«çºè¡šããè«æã§ãã²ãã ã®åé åãã©ã®ç¥å éå£ã«ç±æ¥ããããé«ç²ŸåºŠã»é«éã«æšå®ããæ°ããè§£æææ³ãGnomixããéçºãã人ãšç¬ç§åç©ã®å šã²ãã ããŒã¿ã§æ§èœãæ€èšŒãããã®ã ãç ç©¶ããŒã ã¯å®èšŒã®å¯Ÿè±¡ãšããŠãã¡ãã·ã³åç£ã®ãã¯ã¯ãšç¡æ¯ç¬çš®ã·ã§ãã€ãã¯ã€ã³ãã¬ïŒã·ã§ãïŒãéžãã ãã¢ã¡ãªã«å€§éžã®ç¬ã®å€ãã¯15äžçŽä»¥éã®æ€æ°å°åã«äŒŽã£ãŠãšãŒãããããæã¡èŸŒãŸããç¬çš®ã®åå«ã ããå è¡ç ç©¶ã§ã¯ãã¯ã¯ã«4%ãã·ã§ãã«3%ããšãŒãããäººå°æ¥åã®ãå äœç¬ãã®ç¥å æåãæ®ã£ãŠããããšãåãã£ãŠãããä»åã®è§£æã§ã¯ã·ã§ãã®ã²ãã äžã«100äžä»£ä»¥äžããã®ãŒãæ°å€§éžç±æ¥ã®ãããã¿ã€ããç¹å®ããããšãŒãããç¬ãšå ã³ãã³ãã¹æã®ç¬ã1700幎ããã«äº€éããŠãããšæšå®ããããããã¯åæã¡ãã·ã³ã§ãšãŒããã人ãšå äœæ°ãæ··è¡ããææãšéãªãããããŠãã¯ã¯ã«ã€ããŠã¯ãã³ãšãŒãç±æ¥ã®éºäŒç©è³ªãå«ãŸããŠããããšã瀺ããããã³ãšãŒãã¯ãã€ã€ããªãªã«ãããããå°ããåç±³åç£ã®éçã€ãç§åç©ã§ã以åããå€ä»£ã¢ã¡ãªã«å€§éžã®å®¶çç¬ã®éªšã®DNAã«ãã³ãšãŒãã®ç¥å æåãèŠã€ãã£ãŠããããã ããã³ãšãŒãã®éºäŒåããã€ãã¯ã¯ã®ç³»çµ±ã«å ¥ã£ãã®ããå¶ç¶ã®äº€éãªã®ãäœäžä»£ãåã®æå³çãªæãåãããªã®ãã¯åãã£ãŠããªãã
ãã€ãæ°ã¯ãèŠæå¿ã匷ãçžåŒµãæèã®åŒ·ãã³ãšãŒãã®è¡ãã倧èã§ç¬ç«å¿ãåŒ·ãæ©æãããã§ããŠæåŸãã§ããããšãããã¯ã¯ã®æ°è³ªãéšåçã«èª¬æãããããããªããšè¿°ã¹ãŠãããäžæ¹ã§äœã®å°ããã¯ã³ãšãŒããšã¯ç¡é¢ä¿ã§ãã»ãŒãã¹ãŠã®å°åç¬çš®ãå ±æããã€ã³ã¹ãªã³æ§æé·å å1ïŒIGF1ïŒéºäŒåã®å€ç°ãšãå®¶çåã®ããåæããç¶ã人çºéžæã®ç£ç©ã ãšãããç¬ã¯1äž5000幎以äžåã«å®¶çåãããæãå€ãå®¶çã®ã²ãšã€ã§ãäžçã®åäœæ°ã¯7åã10åé ãšæšå®ãããç¬çš®éã®äœæ Œå·®ã¯40åã«éããããã€ãæ°ã¯ããããã倿§ãªæŽå²ãæã€ç¬ãšæ®ããã«ã¯ãç¬çš®ã®å€èŠã ãã§ãªãããã®ç¬ã®èº«äœçã»å¿ççã»æ ç·çãªããŒãºãçè§£ããããšããã¬ãŒãã³ã°ã®æåãšåæ¹ã®å¹žãã«æ¬ ãããªããšåŒ·èª¿ãããæ¥æ¬ã§ããã¯ã¯ã¯ç»é²é æ°ã®äžäœãå ãã人æ°ç¬çš®ã ãããå°ããããæ£æ©ã¯äžèŠããæ±ã£ãã§æºè¶³ããšèããããã¡ã ãä»åã®ç ç©¶ã¯ãã¯ã¯ãæ¬æ¥ãéåãšç¥çåºæ¿ãå¿ èŠãšããæŽ»çºãªç¬ã§ããããšãæ¹ããŠæãåºãããŠãããããã£ãšããã³ãšãŒãã®è¡ã®å²åãåã ã®ç¬ã®æ§æ Œã決ããããã§ã¯ãªãããã€ãã瀟äŒåã®éèŠæ§ãäžããããã§ããªããå ããèŠæå¿ã®åŒ·ããæ°ã«ãªãå Žåã¯ãç¬çš®ã®ããã«ãããç£å»åž«ãè¡åã®å°éå®¶ã«çžè«ããŠã»ããã
ð¡ 仿¥ã®ã¯ã³ãã€ã³ã
ãµããªã¡ã³ãããå£ã«å ¥ããã®ãã§ãã以äžããããçªå·ãæ§ããŠããç¿æ £ãååæã«åœ¹ç«ã¡ãŸãããããŠãããŒãã«ã ããã¢ã¬ã«ã®ãŒãåºãªããããã¯ã¯ã ããéåã¯ãããªãããšãã£ãç¬çš®ã®ã€ã¡ãŒãžã¯ãç ç©¶ãé²ãã»ã©æ ¹æ ãæºããã§ããŸããç®ã®åã®äžé ããã芳å¯ããäœèª¿ãè¡åã®å€åã¯èšé²ãæã£ãŠãããã€ãã®ç£å»åž«ã«çžè«ããããšããèæ§è察çã«ãæ©æå¯Ÿå¿ã«ãã€ãªãããŸãã
ð± ç«ãã¥ãŒã¹ â 2026.09.12
æ¬æ¥ 2ä»¶
1. ð¥ å»çã»çŸç ã»äºé²
ã15æ³ãè¶ ããç«ã®åæ°ä»¥äžãã«èªç¥çã®ãµã€ã³ââå€é³Žãã»ãã€ã¬ã®å€±æã»éå°ã°ã«ãŒãã³ã°ãã幎ã®ãããã§çä»ããªãã§ããããµã¹A&M倧ã®ç£å»åž«ãèŠåãæ¹ãšæ¯ãæ¹ã解説
ð 2026.09.03
å€ã«ç ããªãã飌ãäž»ãšé¢ãããªããªããå®¶ã®äžã§è¿·ã£ãããã«æ©ãåãââããããé«éœ¢ã®ç«ã®å€åã¯ã幎ã ããããšèŠéããããã¡ã ããå®ã¯èªç¥çïŒèªç¥æ©èœäžå šçå矀ïŒã®å åãããããªããç±³ãããµã¹A&M倧åŠç£å»åŠéšã®ãžã§ãšã«ã»ãã¯ã€ãèšåºå©æã¯ã9æ3æ¥ä»ã®å倧åŠã®è§£èª¬èšäºã§ãç¬ç«ã®èªç¥çã®èŠåãæ¹ãšã±ã¢ã®èŠç¹ããŸãšãããç«ã§ã¯10æ³ååŸããçç¶ãåºå§ããå 霢ãšãšãã«æç çãäžããã15æ³ãè¶ ããç«ã®åæ°ä»¥äžã«èªç¥çãšççŸããªãå åãèŠããããšããïŒç¬ã§ã¯8æ³ã§çŽ10%ã18æ³è¶ ã§çŽ80%ïŒãåæã®ãµã€ã³ãšããŠæããããã®ã¯ãç®çãªããããããããå®¶ã®äžã§ç²çžãããããã¢ãéæ®µãéãã®ã«æéåããåŒã³ãããžã®åå¿ãå€ããã鳎ã声ãå¢ãããã®5ã€ãç«ã«ç¹åŸŽçãªã®ã¯ãæ¯ãæããã»ã©èªåããªãç¶ãããéå°ã°ã«ãŒãã³ã°ã§ãããã«ç«ã¯äžèª¿ãé ãã®ãåŸæãªãã蚺æãé£ãããšææããŠããããããããã®ã¯ããããã®çç¶ãä»ã®ç æ°ãšéãªãç¹ã ãéæ®µãå«ããã®ã¯é¢ç¯çã«ãç²çžã¯èè±çãè èç ã«èŠããé«éœ¢ç«ã«å€ãç²ç¶è ºæ©èœäº¢é²çãè¡åãæŽ»åéãå€ãããããèªç¥çãšçŽããããã蚺æã¯é£Œãäž»ã®èгå¯ã«ããšã¥ã質å祚ãäžå¿ã§ãè¡æ¶²æ€æ»ãç¥çµåŠçæ€æ»ã§ä»ã®ç æ°ãé€å€ãã確å®ã«ã¯MRIãæãæå¹ã ã麻é ãšã³ã¹ããå¿ èŠã«ãªããšãããç£å»çã®é²æ©ã§ç«ãé·çãããããã«ãªã£ãããšããããŠç£å»åž«ã飌ãäž»ãç æ°ãžã®èªèãé«ãŸã£ãããšããèªç¥çããå¢ããŠãããããã«èŠããèæ¯ã ãšãã¯ã€ãæ°ã¯èª¬æããã
èªç¥çãæ²»ãè¬ã¯ãªãããæ¥èª²ãšç°å¢ã®å·¥å€«ã§çç¶ã®é²è¡ããããããçæŽ»ã®è³ªãä¿ã€ããšã¯ã§ãããç«ã«ã¯ããŒãããºã«ãç¥è²ããã¡ãã§äœãšé ã䜿ãããããšã飌ãäž»ãæ¯æ¥æ±ºãŸã£ãæéãäžç·ã«éããããšãå§ããããŠãããéçã®ç«ã«ã¯ãå®å šã§äºæž¬ã§ããç°å¢ããäœãã倧åã§ãå±ãªãå Žæãéãããå®¶å ·ã®è§ãä¿è·ãããæš¡æ§æ¿ããåŒã£è¶ããªã©å€§ããªå€åãé¿ãããšãã£ãé æ ®ãæãããããé£äºé¢ã§ã¯äžéèèªé žïŒMCTïŒããã¿ãã³Eããªã¡ã¬3ãªã©ã®æé žåæåãçç¶æ¹åã«åœ¹ç«ã€å¯èœæ§ãããããããããé åããçæ³é£ã¯ç¬çšãããªããç«çšã¯æªéçºãšããã®ãçŸç¶ã ãæ¥æ¬ã§ãç«ã®å¹³å寿åœã¯15æ³ãè¶ ãã宀å 飌ãã®ç«ã20æ³è¿ããŸã§çããããšã¯çãããªããªã£ãããå€äžã«å€§å£°ã§é³Žããããã€ã¬ã®å Žæãå¿ããããšãã£ãå€åã«æ°ã¥ãããããã€ãã®åé¡ãèåãšããŠæŸçœ®ããããŸãåç©ç é¢ã§ç²ç¶è ºãè èã®æ€æ»ãå«ããŠçžè«ããŠã»ããããã¯ã€ãæ°ã匷調ããã®ã¯ãç²çžãå€é³Žããç¹°ãè¿ãããŠããç«ã¯ãããšå°ãããŠããã®ã§ã¯ãªããç æ°ãªã®ã ããšæãåºãäœè£ãæã€ããšã ããµããªãè¬ã®äœ¿çšã¯ç«ããšã«åå¿ãç°ãªããããå¿ ãç£å»åž«ã®æå°ã®ããšã§è¡ã£ãŠã»ããã
ð·ïž å»çã»çŸç ã»äºé²
2. ðïž ãã¬ãŒãã³ã°ã»è¡åç§åŠ
ç«ããã·ã£ãŒãããšåšåãåã¿ã€ããŠããã³ã¡ã³ãã®75ã93%ã¯ãããããããéãã§ããââ豪ã¢ãã¬ãŒã倧ã”éã³”åç»11æ¬ã»1100ä»¶ã®ã³ã¡ã³ããåæãç«ã®æåŠãµã€ã³ãç¬ãã«å€æããã9ã€ã®ãã¿ãŒã³
ð 2026.08.12
SNSã«ããµãããç«ãšéã¶ãåç»ã®ãªãã«ã¯ãç«ãæããã«å«ãã£ãŠããã®ã«ãéã³ããšããŠæçš¿ãããŠãããã®ãå°ãªããªãããªãŒã¹ãã©ãªã¢ã»ã¢ãã¬ãŒã倧åŠã®åç©ã»ç£å»ç§åŠéšã®ç ç©¶ããŒã ã¯ãYouTubeã»TikTokã»Instagramã»Facebookã§ãéã³ããšé¡ãããŠå ¬éãããŠããåç»ã®ãã¡ãç«ãã·ã£ãŒããšåšåãããåããéããããšããã人ã«ãããããããªã©æç¢ºãªèŠçã®ãµã€ã³ã瀺ããŠãã11æ¬ãéžã³ãããããã«ä»ããèš1100ä»¶ã®ã³ã¡ã³ããåæãããçµæã¯åŠè¡èªAnthrozoösã«æ²èŒããã8æ12æ¥ã«å倧åŠããã¬ã¹ãªãªãŒã¹ãå ¬éããŠãããé©ãã¹ãããšã«ãç«ã®èŠçãæ ã£ãŠããã«ãããããããã©ã®åç»ã§ãã³ã¡ã³ãã®75ã93%ã¯ãã®é¢ããæ¹ã«å¥œæçã ã£ãã人ã«ããã確èªã§ããåç»ã¯11æ¬äž7æ¬ãã£ãããã³ã¡ã³ãã§ã¯è»œãæ±ãããŠãããç ç©¶ããŒã ã¯ã³ã¡ã³ãããåå°çããŒãåæããšããææ³ã§èªã¿è§£ãã9ã€ã®ããŒãã«åé¡ããããæ¬åœã«å«ãªãåããã¯ãïŒéããªããè¡ãåºãŠããªãããéã³ã ïŒããç«ã®èšèãäŒãã£ãŠããªãïŒããã£ã©ã³ã²ãŒãžã®èª€èªïŒããç«ã¯åãã£ãŠãããããã®ãã¡å¿ãéãïŒå«ãã£ãŠãç¶ããã®ã仲è¯ããªãè¿éïŒãããããç«ã®æïŒåãã»åŒã£ãããææ 衚çŸãšè§£éïŒãããã³ã¿ãŒã®æ¬èœãæºãããŠããããã§ããããããããã ç¬ãããããããŠãå¿é ãã人㯔ã¯ã¬ãŒã㌔æ±ããããŠé»ããããããšãããã®ã ãç ç©¶ããŒã ã¯ãããããã³ã¡ã³ããåãªã誀解ã§ã¯ãªããèªç¥çäžååãæã¡æ¶ãããã®åŠèªãæ£åœåãšãã£ãå¿çã¡ã«ããºã ã®è¡šãã ãšåæããç«ã«åãããã女æ§èèŠçãªè¡šçŸãããªãéããªãã®ãããšãã£ãã人éã®æŽå被害è ã責ããèšèãšåãè«æ³ãèŠãããããšã«ãæžå¿µã瀺ããŠããã
ãã®ç ç©¶ãåããããã®ã¯ãéã³ãã®å®çŸ©ãã®ãã®ã ãè¿å¹Žãéã³ã¯ç«ãšã®çµã¥ããããšã³ãªããã¡ã³ãã®ææ®µãšããŠæšå¥šãããŠããããç«ãæ©ã段éã§åºãããããŠãã®åå³ãç¡èŠããããšæ¥æ§ã¹ãã¬ã¹ãçããç¹°ãè¿ãããã°æ ¢æ§åããŠå¥åº·ãæãªããããããããç ç©¶ããŒã ã¯ãããã£ã©ã³ã²ãŒãžã®èªã¿æ¹ãæããã ãã§ã¯è¡åã¯å€ãããããªã人ãããããããããããšè§£éããŠããŸãã®ããšããæã蟌ã¿ããã€ã¢ã¹ã«èžã¿èŸŒãã æè²ãå¿ èŠã ãšããŠãããäžæ¹ã§ãã³ã¡ã³ãã®å€ãã¯ç«ã®çŠç¥ãæ¬æ°ã§æ°ã«ããã人ããã®ãã®ã§ãæå®³ãªé¢ããã¯å ±æã®æ¬ åŠããã§ã¯ãªããSNSã§äŒŒãåç»ã倧éã«ãé¢çœããã®ããšããŠæµéããããšã§ããããããã¯å¹³æ°ããšããæèŠãäœãããŠããé¢ã倧ãããšãããæ¥æ¬ã§ãç«åç»ã¯äººæ°ã³ã³ãã³ãã§ããç«ãã³ãããã·ã£ãŒãããç¬ãã®å®çªã«ãªã£ãŠããããè³ãäŒãããå°Ÿãæ¿ããæ¯ããç³åãéããäœãããã°ããããšãã£ããµã€ã³ã¯ãç«ããã®æç¢ºãªãæåŠãã ãæç«ãšéã¶ãšãã¯ãç«ãèªåããé¢ããããç¶æ³ãä¿ã¡ãå«ãã£ããããæãåŒããç«ãäž»å°æš©ãæã€éã³ããå¿ãããããç«ã®åã¿å·ã»åŒã£ããå·ã¯äººã«ãšã£ãŠãææãªã¹ã¯ãé«ãã®ã§ãç¡çã«ç¶ããŠåŸããã人ã¯èª°ãããªãã
ð·ïž ãã¬ãŒãã³ã°ã»è¡åç§åŠ
ð¡ 仿¥ã®ã¯ã³ãã€ã³ã
仿¥ã®2æ¬ã«å ±éããã®ã¯ãç«ã®ãµã€ã³ã人éã®éœåã§èªã¿æ¿ããªããããšã§ããé«éœ¢ç«ã®å€é³Žããç²çžã¯ããããŸãŸãã§ã¯ãªãç æ°ã®åå³ããããããéã³äžã®åšåãåã¿ã€ãã¯ããããããã§ã¯ãªãããããŠãã®åå³ã§ããç«ã®è¡åãå€ãã£ããšãã¯ããŸãç«ã®åŽããçç±ãèããè¿·ã£ããç£å»åž«ã«çžè«ããŠãã ããã
æ¯æ7æé ä¿¡

ã³ã¡ã³ããæ®ã